244 related articles for article (PubMed ID: 26470968)
1. Rare yeasts causing fungemia in immunocompromised and haematology patients: Case series from Delhi.
Capoor MR; Gupta DK; Verma PK; Sachdeva HC
Indian J Med Microbiol; 2015; 33(4):576-9. PubMed ID: 26470968
[TBL] [Abstract][Full Text] [Related]
2. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
3. Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain.
Fernández-Ruiz M; Guinea J; Puig-Asensio M; Zaragoza Ó; Almirante B; Cuenca-Estrella M; Aguado JM; ;
Med Mycol; 2017 Feb; 55(2):125-136. PubMed ID: 27495321
[TBL] [Abstract][Full Text] [Related]
4. Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis.
Lee JS; Shin JH; Kim MN; Jung SI; Park KH; Cho D; Kee SJ; Shin MG; Suh SP; Ryang DW
J Clin Microbiol; 2007 Mar; 45(3):1005-10. PubMed ID: 17251396
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre.
Chakrabarti A; Rudramurthy SM; Kale P; Hariprasath P; Dhaliwal M; Singhi S; Rao KL
Clin Microbiol Infect; 2014 Feb; 20(2):O83-9. PubMed ID: 24004250
[TBL] [Abstract][Full Text] [Related]
7. Kodamaea ohmeri as an emerging pathogen: a case report and review of the literature.
Al-Sweih N; Khan ZU; Ahmad S; Devarajan L; Khan S; Joseph L; Chandy R
Med Mycol; 2011 Oct; 49(7):766-70. PubMed ID: 21438792
[TBL] [Abstract][Full Text] [Related]
8. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
[TBL] [Abstract][Full Text] [Related]
10. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Durán Graeff L; Seidel D; Vehreschild MJ; Hamprecht A; Kindo A; Racil Z; Demeter J; De Hoog S; Aurbach U; Ziegler M; Wisplinghoff H; Cornely OA;
Mycoses; 2017 Apr; 60(4):273-279. PubMed ID: 28150341
[TBL] [Abstract][Full Text] [Related]
11. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial fungemia due to Trichosporon asteroides: firstly described bloodstream infection.
Kustimur S; Kalkanci A; Caglar K; Dizbay M; Aktas F; Sugita T
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):167-70. PubMed ID: 12088626
[TBL] [Abstract][Full Text] [Related]
13. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report.
Shang ST; Yang YS; Peng MY
J Microbiol Immunol Infect; 2010 Feb; 43(1):77-80. PubMed ID: 20434128
[TBL] [Abstract][Full Text] [Related]
15. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature.
Yang BH; Peng MY; Hou SJ; Sun JR; Lee SY; Lu JJ
Int J Infect Dis; 2009 Nov; 13(6):e493-7. PubMed ID: 19411182
[TBL] [Abstract][Full Text] [Related]
17. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
[TBL] [Abstract][Full Text] [Related]
18. A case report of fungemia due to Kodamaea ohmeri.
Diallo K; Lefevre B; Cadelis G; Gallois JC; Gandon F; Nicolas M; Hoen B
BMC Infect Dis; 2019 Jul; 19(1):570. PubMed ID: 31262263
[TBL] [Abstract][Full Text] [Related]
19. Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Nakase K; Suzuki K; Kyo T; Kohara T; Sugawara Y; Katayama N
Int J Infect Dis; 2012 Jan; 16(1):e2-e4. PubMed ID: 22071235
[TBL] [Abstract][Full Text] [Related]
20. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
Arabatzis M; Abel P; Kanellopoulou M; Adamou D; Alexandrou-Athanasoulis H; Stathi A; Platsouka E; Milioni A; Pangalis A; Velegraki A
Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
